Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FJZHT03 for stable exertional angina
CTR20132630Phase 3Active
- Sponsor
- Changchun University of Chinese Medicine
- Start
- Mar 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of FJZHT03 in coronary arteriosclerosis, stable angina, sponsored by Changchun University of Chinese Medicine. Started Mar 2014; status: active.
02
Drugs
FJZHT03
03
Conditions
coronary arteriosclerosisstable angina
Beyond the preview
Go deeper on CTR20132630.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20132630.